FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 51,250,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, at a public offering price of $0.30 per unit. The warrants have an exercise price of $0.30 per share, are immediately exercisable and will expire five years from the date of issuance. Zosano has granted the underwriter a 30-day option to purchase up to an additional 7,687,500 shares of common stock and/or additional warrants to purchase up to 7,687,500 shares of common stock.
Zosano Pharma Corporation (NASDAQ:ZSAN) with the stream of 2.62% also noticed, India Outlook Therapeutics, Inc. (NASDAQ:OTLK) encountered a rapid change of -0.75% in the last hour of Fridays trading session. The post Sizzling Stock Update: Zosano Pharma Corporation (NASDAQ:ZSAN), Outlook Therapeutics, Inc. (NASDAQ:OTLK) appeared first on Stocks Equity .
Zosano Pharma Corporation (NASDAQ: ZSAN) announced the publication of Phase 1 trial data of influenza vaccine in the Journal of Vaccines and Immunology.  The data demonstrated that a low dose of a

Zosano Pharma Corp Shares Close in on 52-Week Low - Market Mover

08:02am, Friday, 31'st Dec 2021 Kwhen Finance
Zosano Pharma Corp (ZSAN) shares closed today at 0.1% above its 52 week low of $0.48, giving the company a market cap of $57M. The stock is currently down 8.5% year-to-date, down 13.5% over the past 12 months, and down 96.8% over the past five years. This week, the Dow Jones Industrial Average rose 2.1%, and the S&P 500 rose 2.1%. Trading Activity Trading volume this week was 26.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -133.7% The company's stock price performance over the past 12 months lags the peer average by -158.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Zosano Pharma Corporation (NASDAQ:ZSAN) with the stream of 0.13% also noticed, India Matinas BioPharma Holdings, Inc. (AMEX:MTNB) encountered a rapid change of -2.80% in the last hour of Thursdays trading The post Flaming Stock: Zosano Pharma Corporation (NASDAQ:ZSAN), Matinas BioPharma Holdings, Inc. (AMEX:MTNB) appeared first on Stocks Equity .
Zosano Pharma Co. (NASDAQ:ZSAN) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.61 and traded as low as $0.54. Zosano Pharma shares last traded at $0.55, with a volume of 619,163 shares trading hands. The business has a 50 day moving average []
During the last session, Zosano Pharma Corporation (NASDAQ:ZSAN)s traded shares were 0.64 million, with the beta value of the company hitting 3.21. At the end of the trading day, the stocks price was $0.51, reflecting an intraday loss of -4.66% or -$0.02. The 52-week high for the ZSAN share is $3.06, that puts it down Is Zosano Pharma Corporation (NASDAQ: ZSAN) Still A Loss Stock Despite Being Down -3.24% YTD? Read More »
Wall Street analysts expect that Zosano Pharma Co. (NASDAQ:ZSAN) will announce ($0.07) earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Zosano Pharmas earnings. Zosano Pharma posted earnings of ($0.08) per share during the same quarter last year, which would suggest a positive year-over-year growth rate of []
Zosano Pharma Corporation (NASDAQ:ZSAN) with the stream of -1.50% also noticed, India Camber Energy, Inc. (AMEX:CEI) encountered a rapid change of 0.00% in the last hour of Tuesdays trading session. The post Traders cant brush off this: Zosano Pharma Corporation (NASDAQ:ZSAN), Camber Energy, Inc. (AMEX:CEI) appeared first on Stocks Equity .
Brokerages expect Zosano Pharma Co. (NASDAQ:ZSAN) to announce earnings of ($0.07) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Zosano Pharmas earnings. Zosano Pharma reported earnings of ($0.08) per share in the same quarter last year, which would indicate a positive year over year growth rate []
Zosano Pharma Corporation (NASDAQ:ZSAN)s traded shares stood at 0.71 million during the last session, with the companys beta value hitting 3.22. At the close of trading, the stocks price was $0.57, to imply an increase of 1.77% or $0.01 in intraday trading. The ZSAN shares 52-week high remains $3.06, putting it -436.84% down since that This Weeks 8.55% Gain In Zosano Pharma Corporation (NASDAQ: ZSAN) Taught Us Something New Read More »
Zosano Pharma Corporation (NASDAQ:ZSAN) price closed lower on Friday, December 03, dropping -8.47% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
Zosano Pharma Corporation (ZSAN) with the stream of -8.47% also noticed, India Safe-T Group Ltd (SFET) encountered a rapid change of -7.79% in the last hour of Fridays trading session. The post Overview of Different Indicators: Zosano Pharma Corporation (NASDAQ:ZSAN), Safe-T Group Ltd (NASDAQ:SFET) appeared first on Stocks Equity .

Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

02:45am, Tuesday, 30'th Nov 2021 Intrado Digital Media
FREMONT, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock option to purchase 220,000 shares of Zosanos common stock to a new employee as an inducement award.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE